| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q41159551 | A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction |
| Q34522228 | Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition |
| Q56601042 | Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer |
Search more.